<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2021.8193</article-id>
<article-id pub-id-type="publisher-id">OR-0-0-8193</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Shu</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Hu</surname><given-names>Chunmei</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yingxue</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Shi</surname><given-names>Guang</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Yarong</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Huang</given-names></name></contrib>
</contrib-group>
<pub-date pub-type="ppub">
<month>11</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>09</month>
<year>2021</year></pub-date>
<volume>46</volume>
<issue>5</issue>
<elocation-id>242</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Liu et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 36: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="36" page="2398" id="RA1" xlink:href="10.3892/or.2016.4999" ext-link-type="doi">2398-2404</related-article>, 2016; DOI: 10.3892/or.2016.4999</p>
<p>Following the publication of this paper, it was drawn to the Editors attention by a concerned reader that the GAPDH bands shown in the western blots in Fig. 6A were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere prior to its submission to <italic>Oncology Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
